Literature DB >> 2842917

Cutaneous neoplasms in dogs associated with canine oral papillomavirus vaccine.

C L Bregman1, R S Hirth, J P Sundberg, E F Christensen.   

Abstract

A spectrum of proliferative cutaneous lesions occurred in 12 dogs at the injection site of live canine oral papillomavirus (COP) vaccine, suggesting a viral etiology for the masses. Lesions included epidermal hyperplasia, epidermal cysts, squamous papilloma, basal cell epithelioma, and squamous cell carcinoma. Peroxidase-antiperoxidase staining of tumor sections revealed nuclei which stained for group-specific papillomavirus antigen in five of 12 masses. Electron microscopic examination of tumor sections did not reveal virions. In transmission studies, macerated tumor tissue did not produce oral papillomas on the scarified mucosa of puppies; this procedure did protect the puppies from development of lesions when challenged with infectious papilloma material. These findings are evidence that COP can induce hyperplastic and neoplastic lesions in sites other than oral, pharyngeal, and ocular mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2842917     DOI: 10.1177/030098588702400602

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  10 in total

1.  Rabbit genital tissue is susceptible to infection by rabbit oral papillomavirus: an animal model for a genital tissue-targeting papillomavirus.

Authors:  S B Harvey; N M Cladel; L R Budgeon; P A Welsh; J W Griffith; C M Lang; N D Christensen
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs.

Authors:  Michael H Goldschmidt; Jeffrey S Kennedy; Douglas R Kennedy; Hang Yuan; David E Holt; Margret L Casal; Anne M Traas; Elizabeth A Mauldin; Peter F Moore; Paula S Henthorn; Brian J Hartnett; Kenneth I Weinberg; Richard Schlegel; Peter J Felsburg
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  A multimeric L2 vaccine for prevention of animal papillomavirus infections.

Authors:  Subhashini Jagu; Nicole Malandro; Kihyuck Kwak; Hang Yuan; Richard Schlegel; Kenneth E Palmer; Warner K Huh; M Saveria Campo; Richard B S Roden
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

4.  Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay.

Authors:  C E Lange; K Tobler; C Favrot; M Müller; J O Nöthling; M Ackermann
Journal:  Clin Vaccine Immunol       Date:  2008-11-26

5.  Subcutaneous hemangiosarcoma induced by a foreign body (steel staple) in a cat.

Authors:  Rommel Max Tan; Kuldeep Singh; Kristi Sandman
Journal:  Can Vet J       Date:  2013-04       Impact factor: 1.008

Review 6.  Immunomanipulative strategies for the control of human papillomavirus associated cervical disease.

Authors:  R W Tindle
Journal:  Immunol Res       Date:  1997       Impact factor: 4.505

7.  Viral genome integration of canine papillomavirus 16.

Authors:  Jennifer Luff; Michelle Mader; Peter Rowland; Monica Britton; Joseph Fass; Hang Yuan
Journal:  Papillomavirus Res       Date:  2019-02-13

8.  Mandibular Ossifying Fibroma and Multiple Oral Papillomas in a Roe Deer (Capreolus capreolus).

Authors:  Samoa Zürcher-Giovannini; Thomas-Daniel Ruder; Roy Pool; Karoly Erdelyi; Francesco C Origgi
Journal:  Front Vet Sci       Date:  2020-04-02

9.  New insights into Canis familiaris papillomaviruses genetics and biology: Is the genetic characterization of CPV types and their variants an important clinical issue?

Authors:  Jordana Dantas Rodrigues Reis; Marcus Vinicius de Aragão Batista
Journal:  Genet Mol Biol       Date:  2022-09-12       Impact factor: 2.087

10.  p16 Immunostaining of Canine Squamous Cell Carcinomas Is Not Associated with Papillomaviral DNA.

Authors:  Silvia Sabattini; Federica Savini; Laura Gallina; Alessandra Scagliarini; Patrizia Bassi; Giuliano Bettini
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.